These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9577151)

  • 21. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP; Lee N; Soong YK
    J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
    Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
    Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women.
    Sator PG; Sator MO; Schmidt JB; Nahavandi H; Radakovic S; Huber JC; Hönigsmann H
    Climacteric; 2007 Aug; 10(4):320-34. PubMed ID: 17653959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A; Zhang J; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH; Manning PJ; de Jong SA; Allum AR; Jones SD; Williams SM
    Metabolism; 2001 Mar; 50(3):319-24. PubMed ID: 11230785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
    Okoń A; Jurowski P; Goś R
    Klin Oczna; 2001; 103(4-6):183-6. PubMed ID: 11975014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
    de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
    Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T; Sakuma K; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tear function changes of postmenopausal women in response to hormone replacement therapy.
    Kuscu NK; Toprak AB; Vatansever S; Koyuncu FM; Guler C
    Maturitas; 2003 Jan; 44(1):63-8. PubMed ID: 12568737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Composition, structure and physiologic parameters of the lacrimal system; implications for the concept of ophthalmic forms].
    Ibrahim H; Buri P; Gurny R
    Pharm Acta Helv; 1988; 63(6):146-54. PubMed ID: 3065783
    [No Abstract]   [Full Text] [Related]  

  • 35. Estrogen dysregulation, intraocular pressure, and glaucoma risk.
    Youngblood H; Schoenlein PV; Pasquale LR; Stamer WD; Liu Y
    Exp Eye Res; 2023 Dec; 237():109725. PubMed ID: 37956940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Estrogen Signaling in a Prioritization Study of Intraocular Pressure-Associated Genes.
    Youngblood HA; Parker E; Cai J; Perkumas K; Yu H; Sun J; Smith SB; Bollinger KE; Wiggs JL; Pasquale LR; Hauser MA; Stamer WD; Liu Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex hormone levels and risk of primary open-angle glaucoma in postmenopausal women.
    Kang JH; Rosner BA; Wiggs JL; Pasquale LR
    Menopause; 2018 Oct; 25(10):1116-1123. PubMed ID: 29787481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular findings in Sheehan's syndrome.
    Atmaca M; Kızıldağ E; Candan Z; Özbay MF; Seven İ
    Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):759-63. PubMed ID: 25572357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States.
    Pasquale LR; Loomis SJ; Weinreb RN; Kang JH; Yaspan BL; Bailey JC; Gaasterland D; Gaasterland T; Lee RK; Scott WK; Lichter PR; Budenz DL; Liu Y; Realini T; Friedman DS; McCarty CA; Moroi SE; Olson L; Schuman JS; Singh K; Vollrath D; Wollstein G; Zack DJ; Brilliant M; Sit AJ; Christen WG; Fingert J; Kraft P; Zhang K; Allingham RR; Pericak-Vance MA; Richards JE; Hauser MA; Haines JL; Wiggs JL
    Mol Vis; 2013; 19():1471-81. PubMed ID: 23869166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.
    Kang JH; Wiggs JL; Pasquale LR
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1797-804. PubMed ID: 23412091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.